Search results for: hospital

Reflections on Living with Lupus, and on Treating It

Simon M. Helfgott, MD | April 6, 2012

There are some people whose purpose in life is to entertain. Some of us are fortunate to have them as our patients.

Pediatric Researcher Turns American College of Rheumatology (ACR) Award into a Learning Experience

Staff | April 6, 2012

Yukiko Kimura, MD, has been interested in medical education for a long time, so when the ACR Research and Education Foundation (REF) awarded her the ACR REF Clinician Scholar Educator Award in 2008, she knew what she wanted to do.

Dermatology Case Answer: History of ANCA–Associated Vasculitis, Fever, Rash

Joseph F. Merola, MD, Monica Ramirez, MD | April 6, 2012

A 66-year-old woman with a history of antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis presents with two days of fever and rash.

ACR/ARHP Annual Scientific Meeting Plenary Highlights Targets and Treatments for Several Diseases

Vanessa Caceres | April 6, 2012

Promising therapeutic targets for rheumatic diseases were the focus of a plenary session here at the ACR/ARHP 2011 Annual Scientific Meeting in November. Presenters discussed discoveries and treatments for systemic sclerosis, rheumatoid arthritis, vasculitis, and Behçet’s disease.

Rheumatoid Arthritis Drugs May Cut Cardiovascular Risk

Kathleen Louden | April 6, 2012

Other studies at the ACR/ARHP Annual Scientific Meeting in November examined arthritis treatment, scleroderma screening.

Ethics Forum: Letters from Our Readers—Accepting Gifts

Ines Colmegna, MD | April 6, 2012

We received a few letters in response to the December 2011 Ethics Forum, which asked the question: What is your personal policy about accepting gifts?

ACR Coding Specialist Responds to Letter: Of Coding and Perception

Melesia R. Tillman, CPC-I, CRHC, CHA | April 6, 2012

Thank you for forwarding this concern; feedback on the “Coding Corners” is greatly appreciated. I would like to discuss each issue line by line.

The Mystery of IVIg

Eveline Wu, MD, Michael M. Frank, MD | March 8, 2012

Although initially given as replacement therapy for patients with primary and secondary immunodeficiency states, intravenous immunoglobulin (IVIg) has proven to be effective in the treatment of various autoimmune and inflammatory disorders. This success has led to a dramatic increase in the use of IVIg, with its use as an antiinflammatory agent now vastly surpassing its use in the treatment of immunodeficiencies. Even so, the basis for the antiinflammatory activity of IVIg remains unclear.

First ARHP ‘Best of the Meeting’ Highlights Sleep Research, Osteoporosis Screening, More

Kathleen Louden | March 8, 2012

“The line between ACR and ARHP sessions has totally blurred,” said Donah Zack Crawford, MA, during the presentation, “Highlights from the 2011 ARHP Sessions,” here at the 2011 ACR/ARHP Annual Scientific Meeting held in Chicago in November 2011.

Pain is a Tricky Thing to Treat, or Even Evaluate

Simon M. Helfgott, MD | March 8, 2012

Rheumatology is such a gratifying and emotionally rewarding medical specialty. There is no better feeling than helping patients with conditions whose proper diagnosis and management have eluded other practitioners. A patient with diffuse idiopathic skeletal hyperostosis (DISH) presents with pain, and a major clinical tenet of DISH has been its lack of association with pain.